Correlation of Serum Interleukin-6, TNF-α, Procalcitonin and Leukocyte Count in Patients with Suspected Sepsis

Erfina Lim, Jusak Nugraha

Abstract


Sepsis is a cause of non-cardiac death in the hospital. Early and rapid diagnosis of septic patients is a challenge to
increase the expectancy of life. IL-6 and TNF-α are groups of pro inflammatory cytokines that initiate an initial inflammatory
response. Procalcitonin is a specific marker of bacterial infection. This study aimed to analyze the correlation of serum
cytokine IL-6, TNF-α, procalcitonin and leukocyte count in suspected sepsis patients. This was a cross-sectional
observational study consisting of 45 patients with suspected sepsis with procalcitonin level > 0.5 ng/mL. Procalcitonin level
was measured with Enzyme-Linked Fluorescent Assay (ELFA) (VIDAS), IL-6 and TNF-α levels were measured with the
U-CyTech Human Elisa kit (Bioscience, INC) and leukocyte counts were measured with SYSMEX-XN 1000. It was found in this
study that IL-6 levels ranged in 0 pg/mL – 73.29 ng/mL (mean 29.43 ng/mL), TNF-α levels were 0 pg/mL – 390.5 pg/mL (mean
27.62 pg/mL), and the mean value of leukocytes was 20,139/μL. There was no correlation between leukocyte counts with IL-6
(p=0.798 and r=0.040), TNF-α (p=0.304 and r = -0.160), and procalcitonin (p=0.323 and r = 0.154). There was no correlation
between IL-6 levels with TNF-α levels (p=0.871 and r = -0.025), and procalcitonin levels (p = 0.466 and r = 0.112). There was
a weak negative correlation between TNF-α level and procalcitonin levels (p=0.006 and r = -0.403) and there was a weak
negative correlation between procalcitonin and TNF-α levels in suspected sepsis patients.


Keywords


Sepsis, procalcitonin, IL-6, TNF- α

Full Text:

PDF

References


Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, et al (2010) The Surviving Sepsis Campaign: results of an international guideline based performance improvement program targeting severe sepsis. Intensive Care Med 36:222–231

Pugin J , Meisner M, Leon A, Gendrel D, Lopez AF. Guide for the Clinical Use of Procalcitonin (PCT). Thermo Fisher Scientific Inc. www.thermoscientific.com. Edisi 10. Januari 2011.

Riedel S, Melendez JH, An AT, Rosenbaum JE, Zenilman JM. Procalcitonin as a Marker for the Detection of Bacteremia and Sepsis in the Emergency Department. American Society for Clinical Pathology 2011; 135: 182-189.

Muller B, Becker KL, Schachinger H, Rickenbacher PR, Huber PR, Zimmerli W, Ritz R; Calcitonin precursors are reliable markers for sepsis in a medical intensive care unit. Crit care Med 2000, 28:977-983.

Correia, J.W., Freitas, M.V., Querioz, J.A., Perrin, M.P. and Cavadas, B. 2009. ‘Interleukin-6 blood levels in sensitive and multiresistant tuberculosis’, Infection, 37, pp. 138-141. doi:10.1007/s15010-008-7398-3.

Lloyd MM, Kuyl JM. Comparison of three methods for procalcitonin analysis. Med Tech. June 2012:26(1);48-51.

Arifijanto M V. 2015. Sepsis. In A. Tjokropprawiro A et al., eds. Buku Ajar Ilmu Penyakit Dalam. 2nd ed. Surabaya: Airlangga University Press. pp.701-707.

Ma’at, Suprapto, 2012. Inflamasi. Pusat Penerbitan dan Percetakan UNAIR (AUP). Edisi 1. Hal 18.

Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S, Remick DG, 2011. ‘The Pathogenesis of Sepsis’. Annual Review of Pathology Mechanisms of Disease, 6, pp.19-48.

Pettila V, Hynninen M, Takkunen O, Kuusela P, Valtonen M. Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med. 2002;28:1220–1225.

Spooner E C, Markowitz PN, Sarawlatz PL, 1992. The Role of Tumor Necrosis Factor in Sepsis. Journal Immunology and Immunopathology. Vol.62, pp.S11-S17.

Schuetz P, Chiappa V, Briel M, Greenwald JL. Procalcitonin algorithms for antibiotic therapy decisions. Arch Intern Med. 2011;171(15):1322-1331.

Magrini L, Gagliano G, Travaglino F, Vetrone F, Marino R, et al. Comparison between white blood cell count, procalcitonin and C reactive protein as diagnostic and prognostic biomarkes of infection or sepsis in patients presenting to the emergency department. Clin Chem Lab Med 2014; 52(10): 1465-1472.

Mozes T, Barath I, Gornicsar K, Grosz A, Gondocs Cs, et al. Deviations in Circulating TNF-α levels and TNF-α Production by Mononuclear Cells in Healthy Human Populations. Hindawi Mediators of inflammation 2011; p1-8.

Müller B, Becker KL. Procalcitonin: how a hormone became a marker and mediator of sepsis. Swiss Med Wkly. 2001 Oct 20; 131(41-42):595-602.

Dahaba AA, Metzier H., Procalcitonin’s role in the sepsis cascade. Is procalcitonin a sepsis marker or mediator? Minerva anestesiol.2009 Jul-Aug;75(7-8) :447-52. Epub 2008 Jan 24.

Wrenger S, Kahne T, Bohoun C, Weglohner W, Ansorge S, et al. Amino-terminal truncation of procalcitonin, a marker for systemic bacterial infections, by dipeptidyl peptidase IV (DP IV). 2000 Jan 21; 466(1):155-9.

van Langevelde P, Joop K, van Loon J, Frölich M, Groeneveld PH, et al Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality. JT Clin Infect Dis. 2000 Dec; 31(6):1343-8.




DOI: http://dx.doi.org/10.24293/ijcpml.v26i2.1463

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.